[1] This medication is intended for use as testosterone replacement therapy in males with confirmed hypogonadism or markedly low testosterone levels due to conditions associated with a deficiency or absence of endogenous testosterone
Evidence from in vitro, animal, and small human studies indicates low toxicity
Both rheumatoid arthritis (an autoimmune condition) and osteoarthritis (degenerative joint disease) involve inflammation as a central driver of symptoms and progression
IGF-1 LR3 is a lengthened version of IGF-1
In a study of 83 men with obesity, insulin resistance, and symptoms of low testosterone (including erectile dysfunction), those treated with tirzepatide for just two months saw significantly greater improvements than those receiving traditional testosterone replacement therapy (TRT) or lifestyle changes alone
Ultimately, the success of your work hinges on controlling variables